PGHL Stock Overview
Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Procter & Gamble Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹4,720.85 |
| 52 Week High | ₹5,642.85 |
| 52 Week Low | ₹4,575.00 |
| Beta | 0.45 |
| 1 Month Change | -1.27% |
| 3 Month Change | -10.51% |
| 1 Year Change | 1.70% |
| 3 Year Change | -25.93% |
| 5 Year Change | 28.06% |
| Change since IPO | 1,110.63% |
Recent News & Updates
Recent updates
Weak Statutory Earnings May Not Tell The Whole Story For Procter & Gamble Health (NSE:PGHL)
Feb 14
Procter & Gamble Health (NSE:PGHL) Has Announced That It Will Be Increasing Its Dividend To ₹50.00
Sep 29Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Sep 10Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 27A Look At The Fair Value Of Procter & Gamble Health Limited (NSE:PGHL)
Mar 30We Think The Compensation For Procter & Gamble Health Limited's (NSE:PGHL) CEO Looks About Right
Nov 17Procter & Gamble Health (NSE:PGHL) Has Announced That Its Dividend Will Be Reduced To ₹11.50
Oct 23Procter & Gamble Health's (NSE:PGHL) Dividend Will Be Reduced To ₹11.50
Oct 09Procter & Gamble Health's (NSE:PGHL) Problems Go Beyond Weak Profit
Feb 16Do Procter & Gamble Health's (NSE:PGHL) Earnings Warrant Your Attention?
Oct 04Here's Why I Think Procter & Gamble Health (NSE:PGHL) Is An Interesting Stock
May 10Would Procter & Gamble Health Limited (NSE:PGHL) Be Valuable To Income Investors?
Mar 23Is Weakness In Procter & Gamble Health Limited (NSE:PGHL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 02Should You Be Adding Procter & Gamble Health (NSE:PGHL) To Your Watchlist Today?
Jan 31Here's What Procter & Gamble Health Limited's (NSE:PGHL) Shareholder Ownership Structure Looks Like
Jan 10
Is Procter & Gamble Health Limited (NSE:PGHL) An Attractive Dividend Stock?
Dec 19Is Procter & Gamble Health Limited's (NSE:PGHL) Latest Stock Performance A Reflection Of Its Financial Health?
Dec 01Shareholder Returns
| PGHL | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.4% | -0.1% | 1.8% |
| 1Y | 1.7% | 55.9% | 46.4% |
Return vs Industry: PGHL underperformed the Indian Pharmaceuticals industry which returned 55.9% over the past year.
Return vs Market: PGHL underperformed the Indian Market which returned 46.4% over the past year.
Price Volatility
| PGHL volatility | |
|---|---|
| PGHL Average Weekly Movement | 2.8% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: PGHL has not had significant price volatility in the past 3 months.
Volatility Over Time: PGHL's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 1,407 | Milind Thatte | www.pghealthindia.com |
Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Cosome, Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands.
Procter & Gamble Health Limited Fundamentals Summary
| PGHL fundamental statistics | |
|---|---|
| Market cap | ₹78.36b |
| Earnings (TTM) | ₹2.27b |
| Revenue (TTM) | ₹12.37b |
34.6x
P/E Ratio6.3x
P/S RatioIs PGHL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PGHL income statement (TTM) | |
|---|---|
| Revenue | ₹12.37b |
| Cost of Revenue | ₹3.93b |
| Gross Profit | ₹8.44b |
| Other Expenses | ₹6.17b |
| Earnings | ₹2.27b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
| Earnings per share (EPS) | 136.54 |
| Gross Margin | 68.23% |
| Net Profit Margin | 18.32% |
| Debt/Equity Ratio | 0% |
How did PGHL perform over the long term?
See historical performance and comparison